Online Inquiry

Please note that we are not a pharmacy or clinic, so we are unable to see patients and do not offer diagnostic and treatment services for individuals.

Glycitein

Inquiry
Cat. No.: OB0125LY-085
Size: 20 mg; 50 mg; 100 mg; 200 mg; 250 mg
CAS No.: 40957-83-3
Compound CID: 5317750
Glycitein

Specification

Description: Glycitein inhibits glioma cell invasion through down-regulation of MMP-3 and MMP-9 gene expression.
Formula Weight: 284.26
Stability: 3 years in powder form.
Applications: Glycitein plays several key roles in cell metabolism and cell invasion.
Storage: Storage at -20°C.
Formula: C16H12O5
Appearance: Solid
Purity: 99.5%
Identity: Confirmed by NMR and HPLC.
Relative Density: 1.420 g/cm3

Library Information

Plate Number: AOCL-31
Plate Location: e7
Empty Location: a1-h1; a12-h12
Formulation: 10mM DMSO
Container: 96-well plate
Pathways: Apoptosis
Targets: Apoptosis
Receptors: Apoptosis
DMSO Max Solubility (mg/mL): 50 mg/mL
DMSO Max Solubility (mM): 175.89 mM
Inquiry

Copyright © Protheragen. All rights reserves.